Log In
BCIQ
Print this Print this
 

QPI-1002 (formerly AKli-5, DGFi, I5NP)

  Manage Alerts
Collapse Summary General Information
Company SBI Biotech Co. Ltd.
DescriptionShort interfering RNA (siRNA) that temporarily inhibits p53 expression
Molecular Target p53
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA: siRNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$10.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/23/2010

Undisclosed

$10.0M

Undisclosed

Get a free BioCentury trial today